Conquering rotavirus: From discovery to global vaccine implementation

Journal of Paediatrics and Child Health

Volumn 51, Issue 1, 2015, Pages 34-39

  Bines, Julie E ^a,b,c   Kirkwood, Carl D ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

diarrhoea; gastroenteritis; rotavirus

Indexed keywords

ROTAVIRUS VACCINE;

AUSTRALIA; CHILD DEATH; CHILDHOOD MORTALITY; COLOSTRUM; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFECTION PREVENTION; NONHUMAN; PASSIVE IMMUNIZATION; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REVIEW; ROTAVIRUS; ROTAVIRUS INFECTION; VACCINATION; VIRAL GASTROENTERITIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; GASTROENTERITIS; HEALTH; HISTORY; INFANT; PRESCHOOL CHILD; ROTAVIRUS INFECTIONS; VIROLOGY;

AUSTRALIA; CHILD, PRESCHOOL; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; GASTROENTERITIS; GLOBAL HEALTH; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 84930147224     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12815     Document Type: Review

References (32)

1. Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD,. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programs: a systematic review and meta-analysis. Lancet Infect. Dis. 2012; 12: 136-141.
2. Barnes GL, Townley RR,. Duodenal mucosal damage in 31 infants with gastroenteritis. Arch. Dis. Child. 1973; 48: 343-349.
3. Bishop RF, Davidson GP, Holmes IH, Ruck BJ,. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 1973; 2: 1281-1283.
4. Soenarto Y, Sebodo T, Ridho R, et al. Acute diarrhea and rotavirus infection in newborn babies and children in Yogyakarta, Indonesia, from June 1978 to June 1979. J. Clin. Microbiol. 1981; 14: 123-129.
5. Bishop R,. Discovery of rotavirus: implications for child health. J. Gastroenterol. Hepatol. 2009; 24: S81-85.
6. Fleming FE, Graham K, Takada Y, Coulson BS,. Determinants of the specificity of rotavirus interactions with the α2β1Integrin. J. Biol. Chem. 2011; 286: 6165-6174.
7. Bishop RF, Barnes GL, Cipriani E, Lund JS,. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N. Engl. J. Med. 1983; 309: 72-76.
8. Banyai K, Laszlo B, Duque J, et al. Systemic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccine programs. Vaccine 2012; 30S: A122-130.
9. Mackenzie A, Barnes GL,. Randomised controlled trial comparing oral and intravenous rehydration therapy in children with diarrhoea. BMJ 1991; 303: 393-396.
10. Davidson GP, Daniels E, Nunan H, et al. Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet 1989; 334: 709-712.
11. Blutt S, Matson D, Crawford S, et al. Rotavirus antigenemia in children is associated with viremia. PLoS Med. 2007; 4: e121.
12. Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N. Engl. J. Med. 1996; 335: 1022-1028.
13. Gladstone BP, Ramani S, Mukhopadhya I, et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N. Engl. J. Med. 2011; 365: 337-346.
14. Vesikari T, Matson D, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med. 2006; 354: 22-33.
15. Ruis-Palacios GM, Perez-Schael I, Velazquez F, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med. 2006; 354: 11-22.
16. Path. Rotavirus vaccine and delivery, 2014. Available from: http://sites.path.org/rotavirusvaccine/rotavirus-advocacy-and-communications-toolkit/country-introduction-maps-and-list/ [accessed June 2014].
17. Atherly DL, Lewis KDC, Tate J, Parashar UD, Rheingans RD,. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030. Vaccine 2012; 30S: A7-14.
18. Patel MM, Glass R, Desai R, Tate J, Parashar UD,. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? Lancet Infect. Dis. 2012; 12: 561-570.
19. Dey A, Wang H, Menzies R, Macartney K,. Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program. Med. J. Aust. 2012; 197: 453-457.
20. Ikeda do Carmo G, Yen C, Cortes J, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med. 2011; 8: e1001024.
21. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N. Engl. J. Med. 2010; 362: 299-305.
22. Bines JE, Patel MM, Parashar UD,. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception. J. Infect. Dis. 2009; 200 (Suppl. 1): S282-290.
23. Bines JE, Ivanoff B, Acute intussusception in infants and children: incidence, clinical presentation and management: a global perspective. World Health Organization Vaccines and Biologicals. 2002; WHO/V&B/02.19.
24. Bines JE, Kohl K, Forster J, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004; 22: 569-574.
25. Buttery J, Danchin M, Lee K, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011; 29: 3061-3066.
26. Carlin J, Macartney K, Lee K, et al. Increased risk of intussusception associated with rotavirus vaccines in Australia's national immunization program. Clin. Infect. Dis. 2013; 57: 1427-1434.
27. Zaman K, Dang D, Victor J, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomized, double-blind, placebo controlled trial. Lancet 2010; 376: 615-623.
28. Armah G, Sow S, Breiman R, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomized, double-blind, placebo controlled trial. Lancet 2010; 376: 606-614.
29. Madhi SA, Cunliffe N, Steele AD, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 2010; 362: 289-298.
30. Snelling TL, Andrews RM, Kirkwood CD, Culvenor S, Carapetis JR,. Case-controlled evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in Central Australia. Clin. Infect. Dis. 2011; 52: 191-199.
31. Cameron D, Bishop R, Davidson G, Townley R,. New virus associated with diarrhoea in neonates. Med. J. Aust. 1976; 1: 85-86.
32. Danchin M, Kirkwood C, Lee K, et al. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. Vaccine 2013; 31: 2610-2616.